138 related articles for article (PubMed ID: 3099540)
1. Mucormycosis in diabetic ketoacidosis. Role of unbound iron binding capacity of transferrin.
Abe F; Shibuya H; Tateyama M; Ommura Y; Azumi N; Kimura K
Acta Pathol Jpn; 1986 Oct; 36(10):1507-12. PubMed ID: 3099540
[TBL] [Abstract][Full Text] [Related]
2. Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis.
Gebremariam T; Lin L; Liu M; Kontoyiannis DP; French S; Edwards JE; Filler SG; Ibrahim AS
J Clin Invest; 2016 Jun; 126(6):2280-94. PubMed ID: 27159390
[TBL] [Abstract][Full Text] [Related]
3. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability.
Artis WM; Fountain JA; Delcher HK; Jones HE
Diabetes; 1982 Dec; 31(12):1109-14. PubMed ID: 6816646
[TBL] [Abstract][Full Text] [Related]
4. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.
Liu M; Spellberg B; Phan QT; Fu Y; Fu Y; Lee AS; Edwards JE; Filler SG; Ibrahim AS
J Clin Invest; 2010 Jun; 120(6):1914-24. PubMed ID: 20484814
[TBL] [Abstract][Full Text] [Related]
5. Effects of iron and desferrioxamine on Rhizopus infection.
Abe F; Inaba H; Katoh T; Hotchi M
Mycopathologia; 1990 May; 110(2):87-91. PubMed ID: 2142253
[TBL] [Abstract][Full Text] [Related]
6. Cerebral mucormycosis in diabetic mice after intrasinus challenge.
Waldorf AR; Diamond RD
Infect Immun; 1984 Apr; 44(1):194-5. PubMed ID: 6706405
[TBL] [Abstract][Full Text] [Related]
7. The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis.
Ibrahim AS; Gebremariam T; Lin L; Luo G; Husseiny MI; Skory CD; Fu Y; French SW; Edwards JE; Spellberg B
Mol Microbiol; 2010 Aug; 77(3):587-604. PubMed ID: 20545847
[TBL] [Abstract][Full Text] [Related]
8. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus.
Waldorf AR; Ruderman N; Diamond RD
J Clin Invest; 1984 Jul; 74(1):150-60. PubMed ID: 6736246
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous mucormycosis caused by Rhizopus oryzae probable nosocomial acquired infection.
Telles Filho Fde Q; Coelho A; Porto E; Lameira RF; Freitas MM; Barboza J; Ramos JL
Rev Inst Med Trop Sao Paulo; 1985; 27(4):201-6. PubMed ID: 3938565
[No Abstract] [Full Text] [Related]
10. Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.
Spellberg B; Fu Y; Edwards JE; Ibrahim AS
Antimicrob Agents Chemother; 2005 Feb; 49(2):830-2. PubMed ID: 15673781
[TBL] [Abstract][Full Text] [Related]
11. GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis.
Alqarihi A; Gebremariam T; Gu Y; Swidergall M; Alkhazraji S; Soliman SSM; Bruno VM; Edwards JE; Filler SG; Uppuluri P; Ibrahim AS
mBio; 2020 Jun; 11(3):. PubMed ID: 32487760
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of mucormycosis.
Ibrahim AS; Spellberg B; Walsh TJ; Kontoyiannis DP
Clin Infect Dis; 2012 Feb; 54 Suppl 1(Suppl 1):S16-22. PubMed ID: 22247441
[TBL] [Abstract][Full Text] [Related]
13. Heat-killed yeast protects diabetic ketoacidotic-steroid treated mice from pulmonary mucormycosis.
Luo G; Gebremariam T; Clemons KV; Stevens DA; Ibrahim AS
Vaccine; 2014 Jun; 32(29):3573-6. PubMed ID: 24814556
[TBL] [Abstract][Full Text] [Related]
14. Mucormycosis caused by Rhizopus microsporus var. microsporus: cellulitis in the leg of a diabetic patient cured by amputation.
West BC; Oberle AD; Kwon-Chung KJ
J Clin Microbiol; 1995 Dec; 33(12):3341-4. PubMed ID: 8586734
[TBL] [Abstract][Full Text] [Related]
15. Mucormycosis in a diabetic ketoacidosis patient.
Vijayabala GS; Annigeri RG; Sudarshan R
Asian Pac J Trop Biomed; 2013 Oct; 3(10):830-3. PubMed ID: 24075351
[TBL] [Abstract][Full Text] [Related]
16. A closer look at pathogenesis of cerebral mucormycosis in diabetic condition: A mini review.
Khoshbayan A; Didehdar M; Chegini Z; Taheri F; Shariati A
J Basic Microbiol; 2021 Mar; 61(3):212-218. PubMed ID: 33448040
[TBL] [Abstract][Full Text] [Related]
17. Deferiprone iron chelation as a novel therapy for experimental mucormycosis.
Ibrahim AS; Edwards JE; Fu Y; Spellberg B
J Antimicrob Chemother; 2006 Nov; 58(5):1070-3. PubMed ID: 16928702
[TBL] [Abstract][Full Text] [Related]
18. Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.
Ibrahim AS; Bowman JC; Avanessian V; Brown K; Spellberg B; Edwards JE; Douglas CM
Antimicrob Agents Chemother; 2005 Feb; 49(2):721-7. PubMed ID: 15673756
[TBL] [Abstract][Full Text] [Related]
19. Mediastinitis and Bronchial Perforations Due to Mucormycosis.
Dhooria S; Agarwal R; Chakrabarti A
J Bronchology Interv Pulmonol; 2015 Oct; 22(4):338-42. PubMed ID: 26348693
[TBL] [Abstract][Full Text] [Related]
20. [Cutaneous mucormycosis and diabetes: about one observation].
Jemli B; Garsallah H; Lebben I; Ferjeni M; Gargouri S
Bull Soc Pathol Exot; 2005 Dec; 98(5):347-9. PubMed ID: 16425710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
